PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback